(FM) Medicina Nuclear

2017

1. 11C-Methionine-PET in multiple myeloma: A combined study from two different institutions

   Theranostics, Vol. 7, Núm. 11, pp. 2956-2964

2. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging

   Tumor Biology, Vol. 39, Núm. 10, pp. 1-23

3. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

   European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587

4. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype

   Journal of Alzheimer's disease : JAD, Vol. 57, Núm. 2, pp. 447-459

5. Effective dose estimation for oncological and neurological PET/CT procedures

   EJNMMI Research, Vol. 7, Núm. 1

6. Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine

   Journal of Medical Microbiology, Vol. 66, Núm. 7, pp. 946-958

7. Emerging clinical issues and multivariate analyses in PET investigations

   Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404

8. European regulations for the introduction of novel radiopharmaceuticals in the clinical setting

   Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 2, pp. 135-144

9. Ionizing radiation received by patients with osteosarcoma during intra-arterial chemotherapy treatment

   Anales del sistema sanitario de Navarra, Vol. 40, Núm. 1, pp. 85-92

10. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients

    Journal of Vascular and Interventional Radiology, Vol. 28, Núm. 11, pp. 1536-1542

11. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: Is PET imaging of pancreatic beta cell mass feasible?

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 447-455

12. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer

    European Radiology, Vol. 27, Núm. 8, pp. 3190-3198

13. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury

    Journal of Translational Medicine, Vol. 15, Núm. 1

14. Nuevos tiempos para la neuroimagen de Medicina Nuclear en España: ¿de dónde partimos?

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 4, pp. 219-226

15. PET biomarkers: Use of imaging techniques in Alzheimer disease and neurodegeneration clinical diagnosis

    Neurologia, Vol. 32, Núm. 5, pp. 275-277

16. Performance characteristics of the whole-body discovery IQ PET/CT system

    Journal of Nuclear Medicine, Vol. 58, Núm. 7, pp. 1155-1161

17. Position statement on radiopharmaceutical production for clinical trials

    EJNMMI Radiopharmacy and Chemistry, Vol. 2, Núm. 1

18. Procedimientos recomendados de dosimetría de pacientes en tratamientos de hipertiroidismo con I-131: Grupo de trabajo de dosis tras la administración de radiofármacos de la S.E.F.M.

    Revista de Física Médica, Vol. 18, Núm. 2, pp. 143-176

19. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy

    NeuroImage: Clinical, Vol. 13, pp. 386-394

20. Toxicity and biodistribution of orally administered casein nanoparticles

    Food and Chemical Toxicology, Vol. 106, pp. 477-486